{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Study+Product&page=87", "query": { "intervention": "Control Study Product", "page": 87 }, "page_size": 10 }, "pagination": { "page": 87, "page_size": 10, "total_count": 4245, "total_pages": 425, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Study+Product&page=88&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Study+Product&page=86&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-06T09:23:45.326Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01751126", "title": "Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Vernal Keratoconjunctivitis" ], "interventions": [ { "name": "NOVA22007 ''Ciclosporin''", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Santen SAS", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "4 Years to 18 Years" }, "enrollment_count": 169, "start_date": "2013-04-29", "completion_date": "2016-02", "has_results": true, "last_update_posted_date": "2022-03-28", "last_synced_at": "2026-11-06T09:23:45.326Z", "location_count": 4, "location_summary": "Glendale, California • Irvine, California • Rancho Cordova, California + 1 more", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Rancho Cordova", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01751126" }, { "nct_id": "NCT02923115", "title": "Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Pulmonary Embolism", "Thrombotic Disease" ], "interventions": [ { "name": "DS-1040b", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Enoxaparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 134, "start_date": "2016-06-23", "completion_date": "2019-08-05", "has_results": true, "last_update_posted_date": "2023-04-19", "last_synced_at": "2026-11-06T09:23:45.326Z", "location_count": 15, "location_summary": "Mobile, Alabama • Beverly Hills, California • San Diego, California + 12 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Beverly Hills", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02923115" }, { "nct_id": "NCT04463017", "title": "Ascending Dose Study of HU6 in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "NASH - Nonalcoholic Steatohepatitis" ], "interventions": [ { "name": "HU6", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rivus Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 64, "start_date": "2020-08-12", "completion_date": "2021-04-01", "has_results": false, "last_update_posted_date": "2021-05-04", "last_synced_at": "2026-11-06T09:23:45.326Z", "location_count": 1, "location_summary": "Saint Paul, Minnesota", "locations": [ { "city": "Saint Paul", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04463017" }, { "nct_id": "NCT01422226", "title": "Intra Uterine Device Insertion in Nulliparous Women", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Contraception" ], "interventions": [ { "name": "Misoprostol", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 3, "start_date": "2011-07", "completion_date": "2012-08", "has_results": true, "last_update_posted_date": "2017-02-02", "last_synced_at": "2026-11-06T09:23:45.326Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01422226" }, { "nct_id": "NCT02310750", "title": "A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06700841, With Bioavailability/Food Effect Investigation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "PF-06700841 oral solution/suspension", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "PF-06700841 tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 96, "start_date": "2014-11", "completion_date": "2016-02", "has_results": true, "last_update_posted_date": "2017-03-08", "last_synced_at": "2026-11-06T09:23:45.326Z", "location_count": 1, "location_summary": "Anaheim, California", "locations": [ { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02310750" }, { "nct_id": "NCT02128490", "title": "Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gout", "Moderate Renal Impairment" ], "interventions": [ { "name": "Febuxostat IR", "type": "DRUG" }, { "name": "Febuxostat XR", "type": "DRUG" }, { "name": "Febuxostat placebo", "type": "DRUG" }, { "name": "Colchicine", "type": "DRUG" }, { "name": "Naproxen", "type": "DRUG" }, { "name": "Lansoprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 189, "start_date": "2014-05", "completion_date": "2015-10", "has_results": true, "last_update_posted_date": "2016-11-03", "last_synced_at": "2026-11-06T09:23:45.326Z", "location_count": 89, "location_summary": "Birmingham, Alabama • Muscle Shoals, Alabama • Phoenix, Arizona + 75 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02128490" }, { "nct_id": "NCT01941043", "title": "A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "CERC-301", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Avalo Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 1357, "start_date": "2013-11", "completion_date": "2014-10", "has_results": false, "last_update_posted_date": "2017-12-21", "last_synced_at": "2026-11-06T09:23:45.326Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Culver City, California + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Culver City", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01941043" }, { "nct_id": "NCT02712008", "title": "Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Macular Edema" ], "interventions": [ { "name": "REGN910-3", "type": "DRUG" }, { "name": "Intravitreal Aflibercept Injection (IAI)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 302, "start_date": "2016-03-02", "completion_date": "2017-07-10", "has_results": true, "last_update_posted_date": "2018-10-03", "last_synced_at": "2026-11-06T09:23:45.326Z", "location_count": 51, "location_summary": "Mesa, Arizona • Tucson, Arizona • Arcadia, California + 48 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Arcadia", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Mountain View", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02712008" }, { "nct_id": "NCT03345225", "title": "A Clinical Study of Precision TACE (P-TACE) With Surefire", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Unresectable Hepatocellular Carcinoma" ], "interventions": [ { "name": "SureFire Infusion System", "type": "DEVICE" }, { "name": "Standard Endhole Microcatheter", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2018-05", "completion_date": "2021-11", "has_results": false, "last_update_posted_date": "2018-09-11", "last_synced_at": "2026-11-06T09:23:45.326Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03345225" }, { "nct_id": "NCT01196091", "title": "A Study of LY2127399 in Participants With Systemic Lupus Erythematosus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Systemic Lupus Erythematosus", "Connective Tissue Disease", "Autoimmune Disease" ], "interventions": [ { "name": "LY2127399", "type": "DRUG" }, { "name": "Placebo every 2 weeks", "type": "DRUG" }, { "name": "Placebo every 4 weeks", "type": "DRUG" }, { "name": "Standard of Care", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1164, "start_date": "2010-12", "completion_date": "2015-06", "has_results": true, "last_update_posted_date": "2018-06-12", "last_synced_at": "2026-11-06T09:23:45.326Z", "location_count": 88, "location_summary": "Birmingham, Alabama • Glendale, Arizona • Mesa, Arizona + 85 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Paradise Valley", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01196091" } ] }